Pfizer Inc. (PFE) Q2 2013 Earnings Results

Pfizer Beats on EPS, Stock Up 0.44%

Pfizer's earnings report shows a positive surprise in EPS, which contributed to a slight increase in stock price. The lack of revenue data and guidance may leave some investors cautious. Overall, the company appears to be on a stable path, but further clarity on future performance is needed.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.56	N/A	+3.32%

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed confidence in their current projects and emphasized the need for continued innovation. They are focused on navigating market challenges.

Management highlighted ongoing efforts in research and development.

They noted the importance of maintaining strong operational efficiency.

Pfizer Beats on EPS, Stock Up 0.44%

Key numbers

Management commentary

Pfizer Inc.

More earnings this week

Pfizer Beats on EPS, Stock Up 0.44%

Key numbers

Management commentary